AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04900064 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief interventions
Description: 'Brief Interventions' (BI) is a generic term for a multitude of tools and interventions used in patient visits within PCBH. BI start immediately at the initial consultation, which ends with a personally tailored and evidence-informed plan adjusted to the patient's context. As such, there is no separation between assessment and intervention. The interventions within BI often have their foundation in CBT, ACT or Motivational Interviewing (MI). The common theme is that they are principle-based rather than manual-based and focus on behavioural change in relation to a problem, rather than focusing on a specific diagnosis. Follow-up appointments are scheduled flexibly depending on the patient's perceived need. A BI treatment usually consists of 1-4 appointments with several weeks apart and has an open ending, where the patient easily can schedule a new appointment. Clinicians delivering brief interventions will have had 3 days of training as well as regular supervision.
Study NCT04900064 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-help CBT
Description: The patient receives a previously scientifically evaluated CBT-based self-help book for one of the following conditions: depression, generalized anxiety disorder, panic disorder, social anxiety, health anxiety, insomnia, or stress/burnout. The therapist support consists of 3-6 contacts throughout the 6-12 weeks long intervention period as decided by the clinician and patient together, as long as at least one and not more than three are physical visits at the center and the rest via phone, video conferencing, or secure internet messages. Clinicians delivering self-help CBT will need four days of reading and two days of training as well as regular supervision to be able to make initial assessments and problem profiling and use the self-help books.
Study NCT04703101 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Given IV
Study NCT04703101 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluorouracil
Description: Given IV
Study NCT04703101 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Radiation Therapy
Description: Undergo IMRT
Study NCT04664491 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standardized COPD management
Description: In standardized management group, patients will receive a multifaceted and integrated disease management that follows recommendations in GOLD 2020 and China Guideline on COPD care. It contains the components below.~1. Maintenance therapy after initial treatment. In this study, patients' initial therapy is the prescribed inhalers at baseline. Maintenance therapy is the medications (LABA, LAMA, or ICS) prescribed for regular or long-term use after initial therapy.~2. Long-term follow-up and routine monitoring of symptoms measured by CAT, mMRC and SGRQ.~3. Regular pulmonary function testing for lung function monitoring~4. Strengthened COPD education~5. Behavioral modification, eg. encouragement of influenza/pneumococcal vaccination, providing smoking cessation counseling and pulmonary rehabilitation.
Study NCT04664491 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Routine COPD management
Description: Patients will undergo usual care according to current clinical practice in study sites. Usual care is the routine care provided to patients. Prescription and dispense of medicine for COPD initial and maintenance therapy will be at the discretion of doctors.
Study NCT04703101 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leucovorin
Description: Given IV
Study NCT04703101 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Given IV
Study NCT06037655 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Total Neoadjuvant Treatment
Description: Adebrelimab (1200 mg) every three weeks intravenously; Mecapegfilgrastim (6 mg) every three weeks intravenously; Gemcitabine (1000 mg/m2) every three weeks on days 1 and 8 intravenously; Cisplatin (25 mg/m2) every three weeks on days 1 and 8 intravenously
Study NCT06739265 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Golidocitinib plus CHOP
Description: Phase 1: dose escalation phase. Drug Golidocitinib: 2 dose level of 150 mg qod and 150 mg qd; CHOP regimen: cyclophosphamide (750 mg/m2 intravenously on day 1), epirubicin (70 mg/m2 intravenously on day 1), vindesine (4 mg intravenously on day 1), and prednisone (60 mg/m2 orally on days 1-5) in a 3-week cycle. Phase 2: dose expansion phase. Drug Golidocitinib: RP2D established in the phase I study; CHOP regimen: cyclophosphamide (750 mg/m2 intravenously on day 1), epirubicin (70 mg/m2 intravenously on day 1), vindesine (4 mg intravenously on day 1), and prednisone (60 mg/m2 orally on days 1-5) in a 3-week cycle.
Study NCT04703101 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT04703101 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Surveillance
Description: Undergo NOM
Study NCT04703101 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Total Mesorectal Excision
Description: Undergo TME
Study NCT04942457 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fasting
Description: Prolonged fasting for 7-10 days (caloric intake \<500 kcal in liquid form)
Study NCT06530186 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LiviWell Postcoital Vaginal Insert
Description: subjects will use Livi within minutes of completion of sex, and will remove study device in under an hour.
Study NCT05814354 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1811
Description: SHR-A1811 is a lyophilized powder for injection intravenously. Administered according to label, as one option for Physician's Choice.
Study NCT05814354 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Capecitabine/Eribulin/Gemcitabine/Paclitaxel/Nab-paclitaxel
Description: Administered according to label, as one option for Physician's Choice (determined before randomization).
Study NCT04991818 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: OneBiome microbiome profiling service
Description: participants will be asked to complete the user experience of the OneBiome service
Study NCT06737848 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single catheter adrenal vein sampling
Description: The clinical invasive procedure involves inserting a single catheter into the right and left adrenal veins to collect blood samples from both adrenal veins.
Study NCT06737848 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Double catheters adrenal vein sampling
Description: The clinical invasive procedure involves inserting double catheters into the right and left adrenal veins to collect blood samples from both adrenal veins.
Study NCT06505967 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Qualia NAD+
Description: Qualia NAD+ is a novel dietary supplement, formulated to support the maintenance and enhancement of intracellular NAD levels.
Study NCT05308108 — intervention group
Intervention type: PROCEDURE
Intervention: (Adeno)tonsillectomy
Description: registration of PORC in children with OSAS after (adeno)tonsillectomy
Study NCT05361096 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational approach (Flipped learning)
Description: In the intervention group, the out-of-class stage started one week before the in-class stage of the relevant week. The researchers covered the topic of the week asynchronously in the virtual classroom in the learning management system. Students have been able to log into the system at anytime and anywhere and study the course video and other course materials repeatedly.~The in-class stage is the session in which the students in the intervention group come together with the researcher synchronously and conduct an online lesson. It was conducted one session per week for four weeks. The course was carried out synchronously on the Zoom platform during the in-class stage.
Study NCT06399081 — intervention group
Intervention type: OTHER
Intervention: Observational
Description: Observational
Study NCT06505967 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Rice flour
Study NCT06738732 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CBD: GT4 Transdermal Delivery System
Description: CBD: GT4 Transdermal Delivery System
Study NCT06737666 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tong-Xie-Yao-Fang
Description: Tong-Xie-Yao-Fang granules were taken 2 bags at a time, 2 times per day at 1h after meal for 4 weeks.
Study NCT06128837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan hydrochloride liposome Injection
Description: Irinotecan hydrochloride liposome Injection 80 mg/m² intravenously Days 1 q2wk
Study NCT06128837 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topotecan
Description: Topotecan 1.2 mg/m² intravenously Days 1-5 q3w
Study NCT06208358 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: tACS
Description: We aim to use tACS devices to improve the disrupted interpersonal interaction among gaming disorder individuals.
Study NCT06208358 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: tACS
Description: We aim to use tACS devices to improve the disrupted interpersonal interaction among gaming disorder individuals.
Study NCT04859491 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Carbohydrate
Description: Participants have a one in three chance of consuming a carbohydrate beverage between two bouts of high-intensity exercise.
Study NCT04859491 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Carbohydrate-Protein
Description: Participants have a one in three chance of consuming a carbohydrate-protein beverage between two bouts of high-intensity exercise.
Study NCT04859491 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants have a one in three chance of consuming a placebo beverage between two bouts of high-intensity exercise.
Study NCT06405204 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Myoinositol
Description: an enzymatic isoform of inositol and belongs to the vitamin B complex family
Study NCT06405204 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Co-Enzyme Q10
Description: a lipid-soluble quinone, acting as an effective antioxidant,
Study NCT06405204 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melatonin
Description: an indoleamine with low molecular weight that is synthesized by different cells and organs in the body. More importantly, melatonin is an outstanding antioxidant
Study NCT06405204 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Folic acid
Description: control
Study NCT05545826 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vibrotactile coordinated reset
Description: The purpose of this study is to test the efficacy of vibrotactile coordinated reset stimulation on human subject participants with early stage Parkinson's disease
Study NCT05616728 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EDP-235
Description: capsule
Study NCT05616728 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: capsule
Study NCT06562868 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bulk-fill Composite Resin
Description: The evaluation of the restorative material according to FDI criteria at baseline, 1 year and 2 years after application
Study NCT06562868 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Posterior Composite Resin
Description: The evaluation of the restorative material according to FDI criteria at baseline, 1 year and 2 years after application
Study NCT06562868 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High-filler Flowable Composite
Description: The evaluation of the restorative material according to FDI criteria at baseline, 1 year and 2 years after application
Study NCT05240417 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pontic-shield technique
Description: A 1mm thick fragment of the vestibular aspect of the root will remain after extraction (partial extraction)
Study NCT05240417 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Alveolar ridge preservation
Description: Particulate deproteinized bovine bone and porcine collagen membrane will be placed after tooth extraction
Study NCT06511349 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YOLT-203
Description: The IP is administered intravenously at the predetermined dose.
Study NCT05094128 — intervention group
Intervention type: DRUG
Intervention: Upadacitinib
Description: Tablet; Oral
Study NCT05517304 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tcVNS
Description: active stimulation with transcutaneous Vagal Nerve Stimulation (tcVNS)
Study NCT05517304 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: sham
Description: sham stimulation
Study NCT06195761 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: computer guided modified ridge splitting technique in horizontal bone deficiency in posterior mandible
Description: treatment plan includes harvesting and fixing the bone graft in posterior mandibular area using a computer-modified surgical guide
Study NCT06195761 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: free hand modified ridge splitting technique in horizontal bone deficiency in posterior mandible
Description: treatment plan includes manually harvesting and fixing the bone graft in posterior mandibular area without a surgical guide.
Study NCT05597566 — intervention group
Intervention type: PROCEDURE
Intervention: modified electroconvulsive therapy
Description: The patient underwent MECT therapy. The treatment instrument is Xingmaitong IV ECT multifunctional treatment instrument (USA, SOMATICS THYMATRON company), fasting for 6 hours before surgery, emptying urine. Routine preoperative preparations were made, followed by intravenous injection of atropine, propofol, and succinylcholine chloride injection, artificial respiration, placement of dental pads, and electroconvulsive therapy. The whole process is completed by an anesthesiologist and a therapist in cooperation with each other. The first 3 times are once a day, and the next 5 times are once every other day. A total of 8 courses of treatment.
Study NCT04936425 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OTSC Stentfix
Description: The OTSC stentfix will be placed during upper endoscopy after a self-expanding metal stent has been deployed.
Study NCT04926155 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: The starting daily dose of metformin is 500mg once daily, and add a dose of 500mg per week until the target dose of 2000mg once daily if tolerated. Metformin will be continued until disease progression.
Study NCT05242861 — intervention group
Intervention type: RADIATION
Intervention: Brachytherapy
Description: Applicator, dose, schedule, technology, image, 3D print, efficacy, toxicity of brachytherapy
Study NCT05171738 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: skeletally anchored distal jet
Description: used from day one and activated every month
Study NCT06411184 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regulator T Cells
Description: Autologous Regulatory T-Lymphocytes 1\*10\^6/kg, 2\*10\^6/kg, 4\*10\^6/kg and 8\*10\^6/kg, respectively until restrictive toxic reaction occurs
Study NCT01231191 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous acetaminophen
Description: Acetaminophen 1000 mg administered over 15 minutes intravenously as soon as feasible intraoperatively.
Study NCT01231191 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Intravenous placebo
Description: Normal saline administered over 15 minutes intravenously as soon as feasible intraoperatively.
Study NCT04910750 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pulse oximetry
Description: Pulse oximeters are a non-invasive, accurate and easy to use method of evaluating blood oxygen saturation
Study NCT04910750 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Clinical Decision Support Algorithm
Description: Tablet-based clinical decision support algorithms, based on guidelines for the assessment and management of sick children under 5 years of age at primary care
Study NCT05575518 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Optimised rifamycin
Description: optimised dose rifampicin with or without moxifloxacin
Study NCT04322695 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rehabilitation Education Care Program
Description: The RECP contained the following domains: (1) assessment and detection of disability; (2) home exercise; (3) activities to improve mobility; (4) dietary management; (5) patient education; and (6) vocational counseling.
Study NCT04392635 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TauTona Pneumoperitoneum Assist Device (TPAD)
Description: The TPAD is an experimental device used to assist with placement of Veress needle during laparoscopic surgery.
Study NCT04392635 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Standard of Care (SOC)
Description: Standard of Care was used for Veress needle insertion.
Study NCT05520242 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Use of small animation movies to increase response in a national health survey
Description: Inclusion of animation movies in the invitation cover letter to a national health survey is tested in an embedded randomized controlled trial in the Danish National Health Survey 2021.
Study NCT05778643 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TaKeTiNa music therapy
Description: TaKeTiNa music therapy uses a group to perform music together. Each member of the group is needed for the synchronization of the whole group. The group actively makes Music with hands, feet, and the voice. At the same time, the therapist frequently introduces new elements into the process and challenges the group in this playful manner. Through this, patients consistently report an increase in mindful awareness and an alleviation of many depressive symptoms, although these effects have not been shown in controlled studies yet.
Study NCT04322695 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Rehabilitation Education Care Program
Description: The RECP contained the following domains: (1) assessment and detection of disability; (2) home exercise; (3) activities to improve mobility; (4) dietary management; (5) patient education; and (6) vocational counseling.
Study NCT06028737 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Docetaxel
Description: 50mg/m2, d1, i.v., every 2 weeks
Study NCT06028737 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: 50mg/m2, d1, i.v., every 2 weeks
Study NCT06028737 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxaliplatin
Description: 85 mg/m², d1, i.v., every 2 weeks
Study NCT05509244 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen
Description: acetaminophen 1g iv dripping at end of surgery
Study NCT05509244 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: acetaminophen 1g iv dripping at end of surgery
Study NCT06028737 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: 85 mg/m², d1, i.v., every 2 weeks
Study NCT06028737 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Leucovorin
Description: 200 mg/m², d1, i.v., every 2 weeks
Study NCT06028737 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leucovorin
Description: 200 mg/m², d1, i.v., every 2 weeks
Study NCT06028737 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluorouracil
Description: 2600 mg/m²d1 i.v. every 2 weeks
Study NCT05509244 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Description: ibuprofen 300mg iv dripping at end of surgery
Study NCT06028737 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluorouracil
Description: 2600 mg/m²d1 i.v. every 2 weeks
Study NCT05925855 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: US with fastum
Description: apply fastum on trigger point with US
Study NCT05925855 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: US with reparil
Description: apply reparil on trigger point with US
Study NCT05925855 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: US with plain gel
Description: apply gel on trigger point with US
Study NCT05381168 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Calcium from fish bone
Description: Calcium from fish bone contained calcium 312 mg and vitamin D 100 IU per capsule.
Study NCT05558345 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contingency Management
Description: A positive reinforcement behavioral treatment with escalating rewards for consecutive negative urine tests, starting at $10 and capped at a maximum of $40 per negative result.
Study NCT05381168 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Calcium carbonate
Description: Calcium carbonate contained calcium 600 mg and vitamin D 200 IU per capsule.
Study NCT04801693 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1819479
Description: BI 1819479